Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients [Phase 2, Phase 3]
Phase 2/3 trial comparing medroxyprogesterone acetate to LNG-IUS for fertility-sparing management in early-stage endometrioid carcinoma and …
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing chemotherapy versus chemoradiotherapy for post-operative endometrial cancer patients with P53 mutation; cu…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Tachosil for the Prevention of Symptomatic Lymph Cysts [Phase 3]
Phase 3 trial update on Tachosil for prevention of symptomatic lymph cysts in gynecologic cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors [Phase 2]
Phase 2 trial evaluating famitinib plus anti-PD1 therapy for advanced renal cell carcinoma, urothelial carcinoma, and gynecologic cancers su…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 endometrial cancer trial for recurrent or persistent disease has been terminated; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer [Phase 2]
Phase 2 trial evaluating the levonorgestrel-releasing intrauterine system for complex atypical endometrial hyperplasia or early-stage endome…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer [Phase 3]
Phase 3 trial comparing external-beam radiation therapy to vaginal brachytherapy after surgery for stage I endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer [Phase 2]
Phase 2 clinical trial evaluating bupropion hydrochloride to improve sexual desire in women with breast or gynecologic cancers has completed…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma [Phase 2]
A Phase 2 clinical trial update for ONC201 in recurrent/refractory metastatic breast cancer and advanced endometrial carcinoma has completed…
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion [EARLY_Phase 1]
Early-phase clinical trial evaluating fluorescein visualization to detect invasion in endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Pembro/Carbo/Taxol in Endometrial Cancer [Phase 2]
Phase 2 trial investigating pembrolizumab, carboplatin, and paclitaxel in endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer [Phase 2]
Phase 2 clinical trial update evaluating intraoperative pathological evaluation for surgical treatment and staging in endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) [Phase 3]
Phase 3 trial MK-3475-775 evaluated lenvatinib plus pembrolizumab versus treatment of physician's choice in advanced endometrial cancer; res…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy [Phase 2]
Phase 2 trial of PM00104 (Zalypsis) in advanced/metastatic endometrial or cervical cancer previously treated with one line of chemotherapy w…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial investigating LNG-IUS as a fertility-preserving treatment for endometrial cancer and atypical endometrial hyp…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer [Phase 2]
Phase 2 clinical trial update on pembrolizumab with radiation and an immune modulatory cocktail in cervical and endometrial/uterine cancers …
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients [Phase 2]
Phase II open-label trial evaluating niraparib in combination with anti-PD1 antibody for recurrent/advanced endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) [Phase 2]
Phase 2 trial evaluating ATG 008 (dual mTORC1/2 inhibitor) or ATG-010 (selective exportin 1 inhibitor) in combination with chemotherapy for …
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback [NA]
A completed clinical trial evaluating activity monitors and tailored feedback for endometrial cancer survivors; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer [Phase 3]
Phase 3 trial evaluating Flexitouch home maintenance therapy versus standard home maintenance therapy for lower-extremity lymphedema followi…
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: Lymph Node Mapping in Patients With Endometrial Cancer [NA]
A completed clinical trial update on lymph node mapping in patients with endometrial cancer, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer [EARLY_Phase 1]
Early-phase trial evaluating medroxyprogesterone acetate with or without entinostat before surgery in endometrioid endometrial cancer; study…
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors [Phase 2]
Phase 2 study of TQ-B3525 tablets in gynecologic tumors with PIK3CA/PIK3R1/2 alterations (advanced endometrial, cervical, and ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium [Phase 2]
Phase 2 trial evaluating bevacizumab and rucaparib in recurrent cervical or endometrial cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation [Phase 3]
Phase 3 trial comparing oral ondansetron to transdermal granisetron for cervical, endometrial, or vaginal cancer patients undergoing pelvic …